Flu H5 Egg Pandemic Low Dose Vaccine, With Adjuvant, Flu H5 Egg Pandemic Medium Dose Vaccine, With Adjuvant, Flu H5 Egg Pandemic High Dose Vaccine, With Adjuvant, Flu H5 Egg Pandemic High Dose Vaccine, Without Adjuvant
Healthy Volunteers, Influenza
Phase I/II
Not Yet Recruiting
Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.
Jul 31, 2026
Rsv+Hmpv Vaccine, Control Vaccine 3, Control Vaccine 4, Control Vaccine 2, Control Vaccine 1
Healthy Volunteers, Respiratory Syncytial Virus Immunization, Human Metapneumovirus Immunization
Phase I/II
Recruiting
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Jul 21, 2026
Dupilumab, Dupilumab Coformulated With Berahyaluronidase Alfa, Sar231893, Dupixent
Healthy Volunteers
Phase I
Active Not Recruiting
Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Berahyaluronidase Alfa and Dupilumab Without Berahyaluronidase Alfa in Healthy Participants
Jun 08, 2026
―
H5 Flu Investigational Medical Product 1, H5 Flu Imp 2, H5 Flu Imp 3, Rsv Imp 4, Rsv Imp 5, Rsv Imp 6, H5 Flu Imp 7, H5 Flu Imp 8, H5 Flu Imp 9, H5 Flu Imp 10, H5 Flu Imp 11, H5 Flu Imp 12
Respiratory Syncytial Virus (Rsv), Influenza A(H5n1)
Phase I
Recruiting
Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18 to 49 Years of Age
Mar 31, 2026
Itepekimab, Regn3500
Chronic Rhinosinusitis With Nasal Polyps
Phase III
Withdrawn
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Adult Japanese Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
Mar 16, 2026
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Sanofi (SNYN) have in its pipeline
SNYN is currently developing the following drugs: Lunsekimig, Sar443765, Flu H5 Egg Pandemic Low Dose Vaccine, With Adjuvant, Flu H5 Egg Pandemic Medium Dose Vaccine, With Adjuvant, Flu H5 Egg Pandemic High Dose Vaccine, With Adjuvant, Flu H5 Egg Pandemic High Dose Vaccine, Without Adjuvant, Belumosudil. These drug candidates are in various stages of clinical development as the company works toward FDA approval.